A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors

NCT03960060 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Adjustment of study strategy

Conditions

Interventions

Sponsor

Shanghai PerHum Therapeutics Co., Ltd.

Collaborators